Skip to main content
logo
Rakovina Therapeutics Inc. (TSXV:RKV)
Canada flag Canada · Delayed Price · Currency is CAD
0.2550
+0.0100 (4.08%)
Sep 18, 2026, 3:59 PM EST

Rakovina Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1122761315
Market Cap Growth
31.13%-92.08%348.09%-52.61%-18.16%-
Enterprise Value
1542861112
Last Close Price
0.260.101.900.851.802.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-0.22----
PB Ratio
-5.2215.146.211.632.091.80
P/TBV Ratio
--83.04-13.065.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.6818.580.330.36--
Net Debt / Equity Ratio
-1.5816.450.030.25-0.15-0.33
Net Debt / EBITDA Ratio
-0.59-0.30-0.03-0.460.391.36
Quick Ratio
0.100.120.722.958.5225.32
Current Ratio
0.150.271.174.099.9926.94
Return on Equity (ROE)
-1352.29%-391.14%-102.34%-54.02%-38.35%-129.24%
Return on Assets (ROA)
-79.62%-98.84%-41.58%-27.53%-23.83%-35.72%
Return on Capital Employed (ROCE)
-619.90%-642.10%-88.10%-49.70%-46.90%-29.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-61.61%-410.47%-15.26%-43.86%-22.21%-35.95%
Buyback Yield / Dilution
-81.77%-119.25%-18.18%-0.03%-30.22%-